openPR Logo

Press Releases by Category Health & Medicine

RSS-Newsfeed

Neuroendocrine Tumors (NETs) Market is expected to reach USD 12 billion by 2034

Neuroendocrine tumors (NETs) are a heterogeneous group of rare malignancies that arise from neuroendocrine cells dispersed throughout the body, most commonly in the gastrointestinal tract, pancreas, and lungs. While NETs are considered rare, their incidence has been rising significantly over the past two decades, largely due to improved diagnostics and heightened awareness among clinicians. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71607 NETs can range from slow-growing tumors to aggressive

Cancer Monoclonal Antibodies Market Poised for Breakthrough Growth Amid Rising D …

Market Size and Growth: The Cancer Monoclonal Antibodies Market size was valued at USD 46,474.80 million in 2021 and is estimated to reach a CAGR of 9.50% over the forecast period 2024-2031, The Cancer Monoclonal Antibodies Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these

Adeno-Associated Virus (AAV) Vectors in Gene Therapy Market Detailed Industry Re …

Introduction Gene therapy has emerged as a transformative force in modern medicine, offering long-term or even curative treatment for genetic and rare diseases. Among the various delivery systems, adeno-associated virus (AAV) vectors have gained prominence due to their low pathogenicity, stable gene expression, and ability to target dividing and non-dividing cells. AAV vectors are being used across a wide range of indications, including neurological, ophthalmological, hematological, and metabolic disorders. With the growing

HR-Positive, HER2-Negative Breast Cancer Market is expected to reach USD 41 bill …

Breast cancer continues to be the most prevalent cancer among women worldwide. Within its various subtypes, hormone receptor (HR)-positive, human epidermal receptor 2 (HER2)-negative breast cancer is the most common, accounting for approximately two-thirds of all breast cancer diagnoses. This subtype is characterized by tumors that express estrogen and/or progesterone receptors but lack HER2 overexpression, making it a unique therapeutic segment with specific treatment options. Download Full PDF Sample Copy of

Cutaneous T-Cell Lymphoma Marketis expected to reach USD 2.3 billion by 2034

Cutaneous T-cell lymphoma (CTCL) is a rare and complex type of non-Hodgkin's lymphoma that primarily affects the skin but can advance to involve the blood, lymph nodes, and internal organs. Its subtypes, including mycosis fungoides and Sézary syndrome, present unique diagnostic and therapeutic challenges. While CTCL accounts for a small proportion of all lymphomas, it remains an area of significant clinical focus due to its chronic nature, treatment resistance, and

Head and Neck Squamous Cell Carcinomas (HNSCCs) Patient Pool Analysis Market Mas …

Introduction Head and neck squamous cell carcinoma (HNSCC) is one of the most prevalent cancers globally, originating in the mucosal linings of the oral cavity, pharynx, and larynx. The disease is strongly associated with risk factors such as tobacco and alcohol consumption, and human papillomavirus (HPV) infection. Despite advancements in diagnosis and treatment, HNSCC remains a serious healthcare burden due to high recurrence and mortality rates. Patient pool analysis plays a vital

Metastatic Colorectal Cancer Market is expected to reach USD 22 billion by 2034

Colorectal cancer (CRC) remains one of the most significant cancer burdens worldwide, ranking among the top three most commonly diagnosed malignancies. Within this spectrum, metastatic colorectal cancer (mCRC) represents a critical stage where cancer has spread beyond the colon to distant organs, most commonly the liver and lungs. The global mCRC market is gaining attention due to the rising incidence of colorectal cancers, evolving treatment paradigms, and advances in targeted

Osteoarthritis Patient Pool Analysis Market Massive Growth opportunity Ahead

Introduction Osteoarthritis (OA) is the most common form of arthritis, affecting millions of people worldwide. Characterized by the breakdown of joint cartilage and underlying bone, OA causes chronic pain, stiffness, and reduced mobility, significantly impairing quality of life. It predominantly affects the knees, hips, hands, and spine, and its prevalence is increasing due to the aging global population, rising obesity rates, and sedentary lifestyles. The patient pool for osteoarthritis is growing rapidly,

Soft Tissue Sarcoma (STS) with Lung Metastases Market Detailed Industry Report A …

Introduction Soft tissue sarcomas (STS) are a rare and heterogeneous group of cancers that develop in connective tissues such as muscles, fat, blood vessels, and nerves. One of the most common sites for metastasis in STS patients is the lungs, often signaling advanced disease and poor prognosis. Lung metastases occur in nearly 50% of patients with high-grade sarcomas, making management of metastatic STS a major challenge in oncology. Recent advancements in chemotherapy,

Bone Metastasis in Solid Tumors Market Growth, Applications, Innovations and Bus …

Introduction Bone metastasis occurs when cancer cells from solid tumors such as breast, prostate, lung, or kidney cancer spread to bone tissue. It is among the most common complications in advanced-stage cancers and can lead to severe pain, fractures, spinal cord compression, and reduced quality of life. With improvements in cancer survival rates, more patients are living longer, but the risk of metastasis - particularly to bones - is increasing. As a

Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Market is expected to reach $6. …

Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, accounting for approximately 15% of all lung cancer cases worldwide. It is characterized by rapid tumor growth, early metastasis, and poor long-term survival. Among SCLC patients, nearly two-thirds are diagnosed with extensive-stage disease (ES-SCLC), where the cancer has spread beyond the lungs, making curative treatment nearly impossible. Download Full PDF Sample Copy of Market Report @

PD-L1 Inhibitors Market Growth, Applications, Innovations and Business Outlook b …

Introduction Immunotherapy has revolutionized cancer treatment, with Programmed Death-Ligand 1 (PD-L1) inhibitors emerging as one of the most transformative breakthroughs in oncology. By blocking the PD-1/PD-L1 immune checkpoint pathway, these drugs restore the body's ability to recognize and attack tumor cells. Their adoption has dramatically changed the prognosis for patients with melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma, and other solid tumors. The global PD-L1 inhibitors market is entering a

Synthetic Biology Market to Surpass USD 67.47 Billion by 2033, Fueled by 20.9% C …

According to DataM Intelligence,the Synthetic Biology Market reached US$ 12.37 Billion in 2024 and is expected to reach US$ 67.47 Billion by 2033, growing at a CAGR of 20.9% from 2025 to 2033. The Synthetic Biology Market involves the design and construction of new biological parts, devices, and systems, or the redesign of existing biological systems for useful purposes. It integrates biology, engineering, and computational sciences, leveraging technologies like CRISPR-Cas9, synthetic

Metastatic HER2+ Breast Cancer Patient Pool Analysis Market is expected to reach …

Breast cancer remains the most common cancer among women globally, and approximately 15-20% of all cases are classified as HER2-positive (HER2+), characterized by overexpression of the human epidermal growth factor receptor 2 (HER2) protein. While targeted therapies such as trastuzumab, pertuzumab, and newer antibody-drug conjugates (ADCs) have significantly improved outcomes, metastatic HER2+ breast cancer (mHER2+ BC) continues to present clinical challenges due to disease progression, resistance to therapy, and limited

Anaplastic Thyroid Cancer (ATC) Market Growth, Applications, Innovations and Bus …

Introduction Anaplastic thyroid cancer (ATC) is one of the rarest but most aggressive forms of thyroid cancer, accounting for less than 2% of thyroid cancer cases yet responsible for a disproportionately high mortality rate. Characterized by rapid progression, local invasion, and resistance to conventional therapies, ATC has historically posed significant treatment challenges. In recent years, however, advances in targeted therapies, immunotherapy, and molecular diagnostics have created new opportunities to improve outcomes for

Liquid Biopsy in Cancer Diagnostics Market Growth, Trends, Consumer Demand and K …

Introduction Cancer diagnostics has entered a transformative era with the rise of liquid biopsy, a minimally invasive technique that analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other biomarkers from body fluids such as blood. Unlike traditional tissue biopsies, liquid biopsy enables early cancer detection, real-time monitoring, and personalized treatment selection. As cancer incidence continues to rise worldwide, demand for non-invasive, accurate, and rapid diagnostic solutions is accelerating. Liquid biopsy

Color Detection Sensors Market to Reach USD 3.1 Billion by 2035, Driven by Autom …

The Color Detection Sensors Market, valued at USD 1.8 billion in 2025, is projected to reach USD 3.1 billion by 2035, expanding at a compound annual growth rate (CAGR) of 5.6%, according to the latest industry analysis. The market is witnessing steady growth due to the increasing adoption of industrial automation, the proliferation of smart devices, and stringent quality standards across global manufacturing sectors. Color detection sensors, which identify and

Uncomplicated Urinary Tract Infections (UTIs) Patient Pool Analysis Market Set t …

Introduction Urinary tract infections (UTIs) are among the most common bacterial infections globally, affecting millions each year. Uncomplicated UTIs primarily occur in otherwise healthy individuals, most frequently women, and are caused by pathogens such as Escherichia coli. These infections, while not life-threatening, impose a significant healthcare and economic burden due to high prevalence, recurrence rates, and widespread antibiotic use. The patient pool for uncomplicated UTIs is expanding due to an aging global

Glioma market is projected to reach USD 7.8 billion by 2034

Gliomas are a diverse group of brain tumors arising from glial cells, which support and protect neurons. They represent the most common type of malignant primary brain tumors, with subtypes ranging from low-grade gliomas (slow-growing) to aggressive forms such as glioblastoma multiforme (GBM). Despite decades of research, gliomas remain difficult to treat due to their invasive nature, resistance to therapies, and limited drug delivery across the blood-brain barrier. Download Full PDF

Non-Muscle Invasive Bladder Cancer (NMIBC) Patient Pool Analysis Market Massive …

Introduction Bladder cancer is one of the most common cancers worldwide, and non-muscle invasive bladder cancer (NMIBC) accounts for nearly 70-75% of all newly diagnosed cases. NMIBC is characterized by tumors confined to the mucosa or submucosa, making it less aggressive than muscle-invasive bladder cancer (MIBC). However, recurrence rates remain high, and progression to advanced stages is a significant concern. The NMIBC patient pool is expanding globally due to an aging population,

Electronic Stethoscope Market Poised for Breakthrough in Digital Healthcare Inno …

Market Size and Growth: The Electronic Stethoscope Market size was valued at USD 342.1 million in 2021 and is estimated to reach at a CAGR of 8.20% over the forecast period 2024-2031. The Electronic Stethoscope Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities.

What is the Europe Biosimilar Market size in 2025?

Europe Biosimilar Market Summary 2025 Market Size in 2024: USD 13,864 Million Market Forecast in 2033: USD 59,733.3 Million Market Growth Rate 2025-2033: 17.1% The Europe biosimilar market was valued at USD 13,864 million in 2024 and is expected to reach USD 59,733.3 million by 2033, expanding at a CAGR of 17.1%. Patent cliffs of blockbuster biologics, rising chronic-disease prevalence, and supportive EMA pathways are converging to create one of the fastest-growing segments in

Vietnam Skin Care Products Market to Surpass USD 1,920.70 Million by 2030 | Risi …

According to the report published by Zion Market Research, the global Vietnam Skin Care Products Market size was valued at USD 860.4 Million in 2022 and is predicted to reach USD 1,920.70 Million by the end of 2030. The market is expected to grow with a CAGR of 10.56% during the forecast period. The report analyzes the global Vietnam Skin Care Products Market's growth drivers, restraints, and impact on demand

Metastatic Triple-Negative Breast Cancer (mTNBC) Patient Pool Analysis Market Ou …

Introduction Triple-negative breast cancer (TNBC) is one of the most aggressive forms of breast cancer, accounting for 10-15% of all cases. TNBC lacks the three common receptors (estrogen, progesterone, and HER2) that drive other breast cancer subtypes, making it particularly difficult to treat. Standard endocrine or HER2-targeted therapies are ineffective, leaving chemotherapy, immunotherapy, and emerging targeted agents as the main treatment options. When TNBC progresses to the metastatic stage (mTNBC), prognosis is

Pediatric Relapsed and Refractory Neuroblastoma Market is expected to reach USD …

Neuroblastoma is one of the most common pediatric solid tumors, primarily affecting children under the age of five. While frontline therapies such as surgery, chemotherapy, radiation, and stem cell transplantation have improved survival in standard-risk patients, the prognosis for relapsed and refractory neuroblastoma remains poor. Children whose disease returns after initial treatment or who fail to respond to frontline therapies face limited therapeutic options and a high risk of mortality. Download

BCG-unresponsive NMIBC market is projected to reach $4.1 billion by 2034

Bladder cancer is among the most common urologic malignancies worldwide, with non-muscle invasive bladder cancer (NMIBC) representing approximately 70-75% of all new cases. Standard first-line therapy involves transurethral resection followed by intravesical instillation of Bacillus Calmette-Guérin (BCG). While effective in many cases, a significant subset of patients becomes BCG-unresponsive, meaning their disease progresses or recurs despite adequate treatment. This presents a serious clinical challenge, as these patients are at high

Bone Grafts and Substitutes Market Set to Redefine Orthopedic Solutions with Acc …

Market Size and Growth: The Global Bone Grafts and Substitutes Market size reached US$ 3.46 billion in 2023 and is expected to reach US$ 5.77 billion by 2031, growing at a CAGR of 6.6% during the forecast period 2024-2031. The Bone Grafts and Substitutes Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides

Air Conditioning System Market Set to Surge from USD 138.0 Billion in 2025 to US …

The global air conditioning system market is poised for substantial growth, with its value projected to increase from USD 138.0 billion in 2025 to USD 251.8 billion by 2035, reflecting a compound annual growth rate (CAGR) of 6.2%. This expansion is fueled by growing demand for energy-efficient, smart, and environmentally sustainable cooling solutions across residential, commercial, and industrial sectors. Click Here for More Information:- https://www.futuremarketinsights.com/reports/air-conditioning-systems-market Rising Demand Amid Urbanization and Climate Change The

Metastatic HR+/HER2- Breast Cancer Patient Pool Analysis Market Growth, Trends, …

Introduction Breast cancer remains the most commonly diagnosed cancer worldwide, with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer representing the largest molecular subtype. Approximately 70% of all breast cancers fall into this category, making it a central focus of oncology research and treatment development. When HR+/HER2- breast cancer progresses to the metastatic stage (mBC), treatment becomes more complex, requiring long-term disease management strategies. Advances in endocrine therapies, targeted inhibitors,

Lymphoedema Market expected to reach $6.2 billion by 2034

Lymphoedema is a chronic, progressive condition characterized by the abnormal accumulation of lymphatic fluid, leading to swelling, discomfort, and reduced mobility. It often develops as a result of lymphatic system damage or obstruction, typically following cancer treatment (such as surgery or radiation) or due to congenital abnormalities. Left unmanaged, lymphoedema can cause recurrent infections, tissue changes, and significant reductions in quality of life. Download Full PDF Sample Copy of Market Report

Anticoccidial Drugs Market Poised for Robust Growth Driven by Livestock Sector E …

Market Size and Growth: The Anticoccidial Drugs Market size was valued at USD 1,137.80 million in 2022 and is estimated to reach a compound annual growth rate (CAGR) of 8.7% over the forecast period 2024-2031. The Anticoccidial Drugs Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize

Esophageal Cancer Patient Pool Analysis Market Insights and Future Outlook

Introduction Esophageal cancer is one of the most lethal gastrointestinal malignancies, ranking among the top ten causes of cancer-related deaths globally. The disease is primarily classified into two subtypes: squamous cell carcinoma (ESCC) and adenocarcinoma (EAC). Both subtypes have distinct geographical prevalence patterns, risk factors, and treatment responses, creating a complex and evolving market landscape. The esophageal cancer patient pool analysis market plays a vital role in understanding treatment demand, patient demographics,

Pheochromocytomas and Paragangliomas (PPGL) Market to Set Phenomenal Growth From …

Pheochromocytomas and Paragangliomas (PPGL) Market Outlook 2024-2034: Rising Awareness and Targeted Therapies Drive Growth Introduction Pheochromocytomas and paragangliomas (collectively known as PPGL or PCPG) are rare neuroendocrine tumors that originate from chromaffin cells in the adrenal medulla or extra-adrenal paraganglia. While pheochromocytomas arise in the adrenal glands, paragangliomas occur in various parts of the body including the abdomen, chest, and head-and-neck region. Although rare, these tumors can be life-threatening if untreated, often associated

Prostate Cancer Imaging Market Poised for Breakthrough Growth with Next-Gen Diag …

Market Size and Growth: The Prostate Cancer Imaging Market size was valued at USD 913.7 million in 2021 and is estimated to reach at a compound annual growth rate (CAGR) of 5.70% over the forecast period 2024-2031. The Prostate Cancer Imaging Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market

Automated Compounding Devices Market is expected to reach USD 2.3 billion by 203 …

Automated compounding devices (ACDs) have become essential in modern healthcare systems, particularly in hospital pharmacies and oncology centers. These devices are designed to prepare sterile, accurate, and customized doses of intravenous (IV) medications, including chemotherapy drugs, parenteral nutrition, and high-risk injectable therapies. By reducing manual intervention, ACDs significantly improve safety, precision, and efficiency, minimizing the risk of dosing errors and contamination. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71627 The

Anaplastic Large Cell Lymphoma (ALCL) Market New Product Development & Latest Tr …

Introduction Anaplastic large cell lymphoma (ALCL) is a rare and aggressive subtype of non-Hodgkin's lymphoma (NHL) that arises from T-cells. ALCL accounts for a small proportion of lymphomas but is clinically significant due to its aggressive nature and the availability of unique therapeutic pathways, such as targeting the anaplastic lymphoma kinase (ALK) protein in ALK-positive cases. Over the past decade, major breakthroughs in targeted therapies, monoclonal antibodies, and immunotherapy have transformed the

Sezary Syndrome (SS) Market 2025-2034 Business Outlook, Critical Insight and Gro …

Introduction Sezary syndrome (SS) is a rare and aggressive form of cutaneous T-cell lymphoma (CTCL), characterized by the presence of malignant T-lymphocytes in the blood, skin, and lymph nodes. Patients often present with erythroderma, lymphadenopathy, and circulating atypical cells, making management complex. Due to its rarity and poor prognosis, SS represents a significant unmet need in oncology. In recent years, advances in targeted therapies, monoclonal antibodies, and immunomodulators have provided new hope
09-08-2025 | Health & Medicine
Fact.MR

Medical Device Connectivity Market is Valued at US$ 2.29 billion in 2025 and Nor …

Fact.MR today released its latest report on the Medical Device Connectivity Market, forecasting robust growth driven by the rising adoption of telehealth, IoT-enabled medical devices, and advancements in wireless technologies. Valued at USD 2.29 billion in 2025, the global market is projected to expand at a compound annual growth rate (CAGR) of 23.5%, reaching USD 18.86 billion by 2035. This growth underscores the critical role of connectivity solutions in enabling

Peripheral T-Cell Lymphoma (PTCL) Patient Pool Analysis Market is expected to re …

Peripheral T-cell lymphoma (PTCL) is a rare and aggressive type of non-Hodgkin's lymphoma that arises from mature T-cells. Unlike the more common B-cell lymphomas, PTCL has a poorer prognosis, higher relapse rates, and limited standard treatment options. Subtypes such as PTCL-not otherwise specified (PTCL-NOS), angioimmunoblastic T-cell lymphoma (AITL), and anaplastic large cell lymphoma (ALCL) present significant heterogeneity, complicating diagnosis and treatment planning. Download Full PDF Sample Copy of Market Report @

US Sex Reassignment Surgery Market 2025 | Growth Drivers, Key Players & Investme …

Market Size and Growth U.S Sex Reassignment Surgery Market reached USD 2.1 billion in 2022 and is expected to reach USD 4.8 billion by 2030 growing with a CAGR of 11.4% during the forecast period 2023-2030. US Sex Reassignment Surgery Market report, published by DataM Intelligence has released its latest in-depth analysis on the global US Sex Reassignment Surgery Market, delivering a detailed overview of regional growth patterns, market segmentation,

Peripheral T-Cell Lymphoma Market Detailed Industry Report Analysis 2025-2034

Introduction Peripheral T-cell lymphoma (PTCL) is a rare and aggressive type of non-Hodgkin's lymphoma that originates from mature T-cells. Representing only about 10-15% of all non-Hodgkin's lymphomas, PTCL presents significant diagnostic and therapeutic challenges. Patients often face poor prognoses due to late detection and resistance to standard chemotherapy regimens. However, advancements in targeted therapies, monoclonal antibodies, immunotherapies, and cell-based treatments are driving renewed hope for PTCL patients. Pharmaceutical and biotech companies are

Nerve Monitoring Devices Market Expected to Grow Significantly, Aided by Rising …

New York, US - September 8, 2025- The Insight Partners, a leading market research firm, has published a new report indicating that the global nerve monitoring devices market is poised for significant growth. The analysis projects robust expansion, a trend being supported by the increasing occurrence of neurological ailments, a surge in demand for minimally invasive surgical procedures, and continuous technological progress in neurophysiological monitoring. Get a PDF Sample Brochure at

Diabetes Devices Market Surges as Innovation Unlocks Next-Gen Patient Care 2025 …

Market Size and Growth: The Diabetes Devices Market reached US$ 33.4 billion in 2024 and is expected to reach US$ 64.8 billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033. The Diabetes Devices Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize

Submersible Dredge Pumps Market to Reach USD 2.1 Billion by 2035, Driven by Effi …

The global submersible dredge pumps market is poised for steady growth, with a market value estimated at USD 1.3 billion in 2025 and projected to reach USD 2.1 billion by 2035, reflecting a 5.0% CAGR during the forecast period. The market expansion is fueled by increasing demand for high-efficiency pumps across mining, marine construction, wastewater management, and large-scale infrastructure projects. Click Here for More Information:- https://www.futuremarketinsights.com/reports/submersible-dredge-pumps-market Market Growth Drivers The growth of the

Oral Mucositis Market Outlook 2024-2034: Rising Cancer Treatment Needs

Introduction Oral mucositis (OM) is a painful and common complication of chemotherapy and radiotherapy in cancer patients, manifesting as inflammation and ulcerations in the mouth. This condition significantly impairs quality of life, disrupts treatment regimens, and increases healthcare costs. With the global rise of oncology treatments, the oral mucositis market has emerged as a vital segment within supportive care. Forecasts indicate steady market growth through 2034, underpinned by increased cancer incidence, innovation
09-08-2025 | Health & Medicine
Fact.MR

Corneal Topographers Market is Valued at USD 865.5 million in 2025 | Fact.MR Rep …

Fact.MR today released its latest report on the Corneal Topographers Market, projecting consistent growth driven by rising prevalence of vision disorders, increasing access to eye care services, and continuous technological advancements in ophthalmic diagnostics. Valued at USD 865.5 million in 2025, the global market is forecast to expand at a compound annual growth rate (CAGR) of 6%, reaching USD 1,547.8 million by 2035. This growth highlights the essential role of

Profitability of Corporate Wellness Consulting Business Plan in 2025: Expenses, …

Corporate Wellness Consulting Business Plan & Project Report 2025 IMARC Group's "Corporate Wellness Consulting Business Plan and Project Report 2025" offers a comprehensive framework for establishing a successful corporate wellness consulting business. The critical areas, including market trends, investment opportunities, revenue models, and financial forecasts, are discussed in this in-depth report and are therefore useful resources to entrepreneurs, consultants and investors. Whether evaluating the viability of a new venture or streamlining

Global Wound Care Market Set to Surge as Advanced Healing Solutions Gain Momentu …

Market Size and Growth: The Global Wound Care Market reached US$ 18.5 billion in 2023 and is expected to reach US$ 25.4 billion by 2031, growing with a CAGR of 4.5% during the forecast period 2024-2031. The Wound Care Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to

Myasthenia Gravis (MG) Patient Pool Analysis Market is expected to reach USD 17. …

Myasthenia gravis (MG) is a rare, chronic autoimmune neuromuscular disorder that causes muscle weakness and fatigue. It occurs when the body's immune system produces antibodies that block or destroy communication between nerves and muscles, most often targeting acetylcholine receptors (AChR) or other neuromuscular junction components. While MG affects both men and women, it is more common in women under 40 and men over 60. Download Full PDF Sample Copy of Market

Global Medical Imaging Equipment Market to Transform Healthcare Diagnostics with …

Market Overview: The Medical Imaging Equipment Market is expected to grow at a CAGR of 5.7% during the forecast period 2024-2031. The Medical Imaging Equipment Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Medical Imaging Equipment market report is an essential

Go To Page     11267 11266 11265 11264 11263 11262 11261 11260 11259 11258 11047 11046 11045 11044 11043 11042 11041 11040 11039 11038